Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Alpha Teknova, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 52 | 54 | +2 |
| Shares | 6.91M | 6.39M | −518.9K (−7.5%) |
| Value | $58.1M | $21.3M | −$36.7M (−63.2%) |
New holders (8)
Institutions that held Alpha Teknova, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parian Global Management LP | 290,000 | $969.0K | 3.15% |
| Keybank National Association | 160,230 | $535.0K | 0.00% |
| Renaissance Technologies LLC | 32,300 | $108.0K | 0.00% |
| Voya Investment Management LLC | 29,663 | $99.1K | 0.00% |
| Dimensional Fund Advisors LP | 10,846 | $36.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 2,712 | $9.06K | 0.00% |
| China Universal Asset Management Co., Ltd. | 263 | $1.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 26 | $0 | 0.00% |
Sold out (6)
Institutions that held Alpha Teknova, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Nicholas Investment Partners, LP | 715,449 | $6.01M |
| Pura Vida Investments, LLC | 251,112 | $2.11M |
| Allianz Asset Management GmbH | 113,661 | $955.0K |
| SEI Investments Co | 20,802 | $175.0K |
| Citadel Advisors LLC | 20,758 | $175.0K |
| Ameriprise Financial Inc | 18,776 | $158.0K |